Jeff Elkins, President and Chief Executive Officer

Samir Patel, Director of Marketing

Burt Goodson,Director, Scientific Affairs and Technology

Aurelio Valencia, Senior Operations Manager

Jeff Elkins –President and Chief Executive Officer
Mr. Elkins joined FlowMedica following various positions as Vice President of Medtronic/AVE's AAA Business Unit where he oversaw Operations pertaining to the TALENT and ANEURX Stent Graft platforms, including the successful US launch of AneuRx. He joined Medtronic following the company's acquisition of World Medical, a successful start-up company where he held the positions of Vice President of Operations and Chief Technical Officer. Prior to World Medical, Mr. Elkins as part of the start-up senior management team, was responsible for Operations, Manufacturing, and portions of R&D for Cordis Endovascular Systems, the neurointerventional spin-off of Johnson & Johnson/Cordis. In addition, he held various manufacturing and R&D engineering and management positions at Cordis Corporation and Haemonetics during its successful IPO. He received a BS degree in Mechanical Engineering from the University of Massachusetts, Amherst.

Samir Patel – Director of Marketing
Mr. Patel joined FlowMedica August 2002 during the initial formation of the company. He has held a variety of positions in manufacturing, research and product development, quality assurance, sales support and product marketing in the medical device industry.  Mr. Patel joined FlowMedica following his position within the Carotid/Peripheral and Endovascular Solutions Division at Guidant Corp.  At Guidant, he faciliated product development of the first-generation peripheral stent and balloon delivery systems, including the RX Acculink Carotid system, the first FDA-approved carotid system.  Mr. Patel brings his manufacturing expertise from Guidant and Medtronic, where he was in manufacturing of their peripheral and coronary balloons.  He holds a Bachelor of Science degree in Chemical Engineering from UC San Diego and an M.B.A. from San Jose State University.

Burt Goodson – Director, Scientific Affairs and Technology

Mr. Goodson joined FlowMedica, Inc., in July 2002 as part of the company's initial engineering core. Previously, he was Manager of Research and Development for FlowMedica, through the initial product development, approval, and launches of the Benephit products. Mr. Goodson has several years experience in cardiovascular interventional medical devices. Most recently prior to joining FlowMedica, he served as Principal Research Engineer in the Department of Vascular Surgery at the Cleveland Clinic Foundation, developing new endovascular products in thrombolysis and EVAR markets, and generating business plans and intellectual property for potential spin-off companies. Prior to CCF, Mr. Goodson served in various product development and engineering roles at World Medical encompassing design, development, and clinical support for Talent endovascular AAA and TAA products, and following a successful acquisition by Medtronic/AVE, continued in a product development management role within the AneuRx organization. Prior to Medtronic and WMMC, Mr. Goodson held roles in R&D and Manufacturing at Cordis Corporation, engineering and launching various neurovascular and peripheral interventional catheters, guide wires, and embolic products. Mr. Goodson holds a Bachelor of Science degree in Biomedical Engineering from Duke University.

Aurelio Valencia – Senior Operations Manager

Mr. Valencia joined FlowMedica, Inc. in March 2002 during the initial formation of the company.  He has over 15 years experience in the vascular interventional medical device industry. Mr. Valencia joined FlowMedica following his position in R&D at Atrionix and through its successful acquisition by J&J, Mr. Valencia was involved in the development of a circumferential ultrasound ablation catheter technology. Prior to Atrionix, Mr. Valencia served in Manufacturing at Devices for Vascular Intervention (DVI), launching various neurovascular and peripheral interventional catheters, and later in R&D at Medtronic/CardioRhythm developing EP catheter technologies.